Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
The sudden onset of inflammation of heart muscle with myocellular necrosis; this is generally secondary to an infectious cause, and patients often have a recent history of a flu-like illness.
Biomarker and diagnostic research for acute myocarditis has been reported in the published literature.
9 clinical trials registered, 3 recruiting. Interventions under study include drug therapy and other interventions. Pipeline includes 4 PHASE3, 1 PHASE1. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT05949450](https://clinicaltrials.gov/study/NCT05949450) |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 1:11 PM UTC
Common questions about acute myocarditis
Prognostic Role of High Sensitivity Troponin During Follow up in the Evolution of Acute Myocarditis
— |
University Hospital, Grenoble |
NOT_YET_RECRUITING |
[NCT07175948](https://clinicaltrials.gov/study/NCT07175948) | Outcome of Clinical Phenotypes of Pediatric Myocarditis at Assiut University Children Hospital | — | Assiut University | NOT_YET_RECRUITING |
[NCT06522100](https://clinicaltrials.gov/study/NCT06522100) | Corticoid Therapy in Acute Myocarditis | PHASE3 | Assistance Publique - Hôpitaux de Paris | NOT_YET_RECRUITING |
[NCT05974462](https://clinicaltrials.gov/study/NCT05974462) | MYTHS-MR Trial (MYocarditis THerapy With Steroids in Patients With Mildly Reduced Ejection Fraction) | PHASE3 | University Hospital, Antwerp | RECRUITING |
[NCT06312891](https://clinicaltrials.gov/study/NCT06312891) | Value of Heart Rate Lowering Therapy in Acute Myocarditis | — | Assiut University | UNKNOWN |
289 publications have been identified in PubMed for acute myocarditis. Research spans Case Report / Case Series (20%), Review / Meta-Analysis (19%), and Epidemiology / Natural History (18%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 59 | 20% |
Research summaries | 55 | 19% |
Disease patterns and progression | 52 | 18% |
Testing and diagnosis research | 49 | 17% |
Laboratory research | 29 | 10% |
Clinical study results | 23 | 8% |
Other research | 19 | 7% |
New treatment approaches | 3 | 1% |
Maher L (2026). [PMID: 42255180](https://pubmed.ncbi.nlm.nih.gov/42255180/). *Eur Heart J Case Rep*. [Case Report / Case Series]
M'Rabet S (2026). [PMID: 41985646](https://pubmed.ncbi.nlm.nih.gov/41985646/). *Heart Rhythm*. [Epidemiology / Natural History]
Ammirati E (2026). [PMID: 41487093](https://pubmed.ncbi.nlm.nih.gov/41487093/). *Circulation*. [Epidemiology / Natural History]
Fulton AJ (2026). [PMID: 41535991](https://pubmed.ncbi.nlm.nih.gov/41535991/). *Cardiooncology*. [Case Report / Case Series]
Morena A (2026). [PMID: 42175819](https://pubmed.ncbi.nlm.nih.gov/42175819/). *Europace*. [Review / Meta-Analysis]
Dores H (2026). [PMID: 42061508](https://pubmed.ncbi.nlm.nih.gov/42061508/). *Rev Port Cardiol*. [Review / Meta-Analysis]
Kocoglu Barlas U (2026). [PMID: 42145046](https://pubmed.ncbi.nlm.nih.gov/42145046/). *Cardiol Young*. [Epidemiology / Natural History]
Thai TBT (2026). [PMID: 41667850](https://pubmed.ncbi.nlm.nih.gov/41667850/). *Pediatr Res*. [Review / Meta-Analysis]
Palmisano A (2026). [PMID: 41758342](https://pubmed.ncbi.nlm.nih.gov/41758342/). *Eur Radiol*. [Diagnostic / Biomarker]
Chen TM (2026). [PMID: 42255175](https://pubmed.ncbi.nlm.nih.gov/42255175/). *Eur Heart J Case Rep*. [Other]
AI-curated news mentioning acute myocarditis
Updated Sep 14, 2026
A case report details a 35-year-old woman who developed life-threatening fulminant myocarditis following COVID-19 infection. This highlights potential severe cardiac complications associated with the virus.
A recent study published in PubMed explores the link between genetic cardiomyopathy and myocarditis, shedding light on the underlying mechanisms. This research could inform future therapeutic strategies for affected patients.
A recent study characterizes myocarditis associated with systemic lupus erythematosus, highlighting its transition from a rare clinical manifestation to potential subclinical involvement. This research may inform future diagnostic and treatment strategies for affected patients.